A series of meetings were held with members of the communities where the trial was undertaken to explain its purpose. The families of potentially eligible children were visited and asked if they wished their child to join the trial. If this was the case, informed consent was obtained. Children were then allocated to one of eight randomisation groups (four active drugs and four placebo).